CUAMC
VRCA icon

China Universal Asset Management Company’s Verrica Pharmaceuticals VRCA Stock Holding History

China Universal Asset Management Company’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-39
Closed -$1K – 470
2022
Q3 		$1K Buy
+39
New +$1.34K ﹤0.01% 420

Other funds holding VRCA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
CI
Conning Inc Hartford, Connecticut $3.01B AUM 16.23% 1-Year Est. Return

China Universal Asset Management Company's VRCA Position: Q4 2022 in Review

China Universal Asset Management Company sold out of Verrica Pharmaceuticals (VRCA) in Q4 2022, closing a stake of 39 shares — an estimated $1K sold.

China Universal Asset Management Company first reported a position in VRCA in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 50 funds tracked by Wall St. Rank hold VRCA as of Q4 2022.

  • China Universal Asset Management Company reported no remaining Verrica Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • China Universal Asset Management Company sold 39 Verrica Pharmaceuticals shares in Q4 2022, an estimated $1K.
  • China Universal Asset Management Company first reported a position in Verrica Pharmaceuticals in Q3 2022 and held it in 1 quarter.
  • China Universal Asset Management Company's Verrica Pharmaceuticals position peaked at $1K in Q3 2022.
  • 50 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q4 2022.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.